The investigators hypothesized that immediate coronary angiography (CAG) within 2 hours after admission can reduce mortality compared to delayed CAG after stabilization of acute decompensated heart failure (ADHF) in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) complicated by ADHF. Patients with NSTE-ACS complicated by ADHF will be randomized to immediate CAG (coronary angiography \< 2 hours after randomization) or delayed CAG after stablization group by 1:1 fashion. This study is a prospective, non-blinded, randomized trial.
Study objective In this study, investigators aim to compare early coronary angiography (CAG \< 2 hours after randomization) and delayed CAG after stabilization of acute decompensated heart failure (ADHF) in patients with acute non-ST-elevation acute coronary syndrome (NSTE-ACS) complicated by ADHF. This study is a prospective, non-blinded, randomized trial. Study background An ADHF is frequently encountered in patients with NSTE-ACS. Although its incidence has been decreased during the decades, it is still high up to 8-12% at initial presentation of NSTE-ACS. Patients with NSTE-ACS complicated by ADHF is also known to be associated with worse in-hospital and long-term clinical outcomes than those without heart failure (HF). Because revascularization could reduce mortality in these patients, it should be done in all patients with NSTE-ACS with ADHF. Current guidelines recommend immediate CAG within 2 hours after admission in patients with NSTE-ACS complicated by ADHF. However, it is difficult to decide the timing of coronary angiography in these high risk patients. Notably, the most of randomized trials about the timing of coronary angiography in NSTE-ACS excluded these high risk patients, therefore there is lack of evidence for immediate coronary angiography within 2 hours after admission in patients with NSTE-ACS complicated by ADHF. Investigators will compare immediate CAG within 2 hours after admission and delayed CAG after stabilization of ADHF in patients with NSTE-ACS complicated by ADHF by randomized controlled trial. Study hypothesis Immediate CAG within 2 hours after admission can reduce mortality compared to delayed CAG after stabilization of ADHF in patients with NSTE-ACS complicated by ADHF.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
After achievement of informed consent in patients with NSTE-ACS complicated by ADHF, patients will be screened and randomized. Patients will be randomized to immediate CAG group or delayed CAG group. Immediate CAG group will receive CAG within 2 hours after randomization. Patients will receive treatment methods according to CAG results: percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) or medical therapy only by operators' discretion.
After achievement of informed consent in patients with NSTE-ACS complicated by ADHF, patients will be screened and randomized. Patients will be randomized to immediate CAG group or delayed CAG group. Delayed CAG group will receive CAG after stabilization of ADHF; improvement of symptoms and signs of heart failure. Patients will receive treatment methods according to CAG results: percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) or medical therapy only by operators' discretion.
Chonnam National University Hospital
Gwangju, South Korea
Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Time frame: Up to 12 months
Rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
All-cause death, non-fatal myocardial infarction or recurrent ischemia during initial hospitalization
Time frame: Up to 12 months
In-hospital mortality
All-cause mortality during initial hospitalization
Time frame: Up to 12 months
In-hospital cardiac mortality
Cardiac mortality during initial hospitalization
Time frame: Up to 12 months
Rate of procedural complications during coronary angiography or percutaneous coronary intervention
Rate of procedural complications during coronary angiography or percutaneous coronary intervention during initial hospitalization
Time frame: Up to 12 months
Peak level of troponin-I
Peak level of troponin-I during initial hospitalization
Time frame: Up to 12 months
Rate of recurrent ischemia
Rate of recurrent ischemia during initial hospitalization
Time frame: Up to 12 months
Rate of Non-fatal myocardial infarction
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
TREATMENT
Masking
NONE
Enrollment
316
Non-fatal myocardial infarction during initial hospitalization
Time frame: Up to 12 months
Rate of stroke
Rate of stroke during initial hospitalization
Time frame: Up to 12 months
Usage rate of non-invasive positive pressure ventilation
Usage rate of non-invasive positive pressure ventilation during initial hospitalization
Time frame: Up to 12 months
Usage rate of mechanical ventilator
Usage rate of mechanical ventilator during initial hospitalization
Time frame: Up to 12 months
Usage rate of renal replacement therapy
Usage rate of renal replacement therapy during initial hospitalization
Time frame: Up to 12 months
Usage rate of mechanical circulatory support
Usage rate of mechanical circulatory support during initial hospitalization
Time frame: Up to 12 months
Rate of acute kidney injury
Rate of acute kidney injury during initial hospitalization
Time frame: Up to 12 months
Rate of stent thrombosis
Rate of stent thrombosis during initial hospitalization
Time frame: Up to 12 months
Rate of major bleeding
Rate of major bleeding during initial hospitalization (BARC classificiation 3-5)
Time frame: Up to 12 months
Duration of initial hospitalization
Duration of initial hospitalization (days)
Time frame: Up to 12 months
Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Time frame: Up to 1 month
Cumulative incidence rate of all-cause death
Cumulative incidence rate of all-cause death
Time frame: Up to 1 month
Cumulative incidence rate of cardiac death
Cumulative incidence rate of cardiac death
Time frame: Up to 1 month
Cumulative incidence rate of rehospitalization due to heart failure
Cumulative incidence rate of rehospitalization due to heart failure
Time frame: Up to 1 month
Cumulative incidence rate of cardiogenic shock
Cumulative incidence rate of cardiogenic shock
Time frame: Up to 1 month
Cumulative incidence rate of stroke
Cumulative incidence rate of stroke
Time frame: Up to 1 month
Cumulative incidence rate of stent thrombosis
Cumulative incidence rate of stent thrombosis
Time frame: Up to 1 month
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Time frame: Up to 1 month
Cumulative incidence rate of recurrent ischemia
Cumulative incidence rate of recurrent ischemia
Time frame: Up to 1 month
Cumulative incidence rate of non-fatal myocardial infarction
Cumulative incidence rate of non-fatal myocardial infarction
Time frame: Up to 1 month
Cumulative incidence rate of all unplanned revascularization
Cumulative incidence rate of all unplanned revascularization
Time frame: Up to 1 month
Cumulative incidence rate of all-cause death
Cumulative incidence rate of all-cause death
Time frame: Up to 12 months
Cumulative incidence rate of cardiac death
Cumulative incidence rate of cardiac death
Time frame: Up to 12 months
Cumulative incidence rate of rehospitalization due to heart failure
Cumulative incidence rate of rehospitalization due to heart failure
Time frame: Up to 12 months
Cumulative incidence rate of cardiogenic shock
Cumulative incidence rate of cardiogenic shock
Time frame: Up to 12 months
Cumulative incidence rate of stroke
Cumulative incidence rate of stroke
Time frame: Up to 12 months
Cumulative incidence rate of stent thrombosis
Cumulative incidence rate of stent thrombosis
Time frame: Up to 12 months
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Time frame: Up to 12 months
Cumulative incidence rate of recurrent ischemia
Cumulative incidence rate of recurrent ischemia
Time frame: Up to 12 months
Cumulative incidence rate of non-fatal myocardial infarction
Cumulative incidence rate of non-fatal myocardial infarction
Time frame: Up to 12 months
Cumulative incidence rate of all unplanned revascularization
Cumulative incidence rate of all unplanned revascularization
Time frame: Up to 12 months